New Market Research Report: Healthcare, Regulatory and Reimbursement Landscape - South Africa

New Healthcare market report from GlobalData: "Healthcare, Regulatory and Reimbursement Landscape - South Africa"

by Bill Thompson

(WireNews+Co) - Boston, MA - 18 March 2013

GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - South Africa". An essential source of information and analysis on the South African healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, as well as providing insights on the demographic, regulatory, and reimbursement landscape and healthcare infrastructure.

Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

In 2011, South Africa's population was 50.5 million, largely due to a positive balance between the birth rate and mortality rate. The mortality rate is decreasing due to South Africa's improving healthcare infrastructure and medical and diagnostic services. The pharmaceutical market was estimated at $2.5 billion in 2011 and is expected to reach $4.2 billion by 2020 at a projected CAGR of 5.8%. The medical device market was worth approximately $1.9 billion in 2011 and is expected to reach $2.8 billion by 2020 at a projected CAGR of 4.3%.

View Full Report Details and Table of Contents (http://www.fastmr.com/prod/529845_healthcare_regulatory_and_reimbursement_landscape.aspx?afid=201) (http://www.fastmr.com/prod/529845_healthcare_regulatory_and_reimbursement_landscape.aspx?afid=201)

The positive trends in South Africa's healthcare market can be attributed primarily to -

- Increasing awareness of health and well-being in society
- Growth in the healthcare infrastructure
- The increasing availability of medicines

Scope

The report provides information on South Africa's healthcare, regulatory and reimbursement landscape, including -

- Overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are Aspen, Adcock Ingram, Sanofi, Novartis and Roche, and the key players covered for the medical devices market are Siemens Healthcare, Essilor International, Johnson & Johnson, F. Hoffmann-La Roche, and B Braun Melsungen.
- Insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices.
- Detailed analysis of South Africa's political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.

Reasons to buy

The report will enhance your decision-making capability and allow you to -

- Develop business strategies by understanding the trends shaping and driving the healthcare market.
-

Fast Market Research (http://www.fastmr.com?afid=201) is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget.  For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.